CUFinder

MARIA ANGELOPOULOU

About MARIA ANGELOPOULOU

MARIA ANGELOPOULOU, With an exceptional h-index of 39 and a recent h-index of 22 (since 2020), a distinguished researcher at National and Kapodistrian University of Athens, specializes in the field of HEMATOLOGY.

His recent articles reflect a diverse array of research interests and contributions to the field:

Monitoring Humoral Response Following BNT162b2 mRNA Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplantation Patients: A Single-Center Prospective Study along …

Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients

A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity

S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL ANALYSIS OF THE INTERNATIONAL MULTICENTER STUDY CONDUCTED BY ERIC, IN HARMONY.

Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version

Easix Indices Predict CRS and Overall Survival in Adult CAR-T Cell Recipients

EVALUATION OF GONADAL FUNCTION IN YOUNG MEN AND WOMEN DIAGNOSED WITH HODGKIN LYMPHOMA

EVALUATION OF FERTILITY IN WOMEN TREATED WITH THE R‐DA‐EPOCH REGIMEN FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA (PMBCL)

MARIA ANGELOPOULOU Information

University

Position

ASSOCIATE PROFESSOR IN HEMATOLOGY

Citations(all)

5739

Citations(since 2020)

1783

Cited By

4639

hIndex(all)

39

hIndex(since 2020)

22

i10Index(all)

112

i10Index(since 2020)

58

Email

University Profile Page

Google Scholar

MARIA ANGELOPOULOU Skills & Research Interests

HEMATOLOGY

Top articles of MARIA ANGELOPOULOU

Monitoring Humoral Response Following BNT162b2 mRNA Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplantation Patients: A Single-Center Prospective Study along …

2024/4/16

Theodoros P Vassilakopoulos
Theodoros P Vassilakopoulos

H-Index: 23

Angeliki Papapanagiotou
Angeliki Papapanagiotou

H-Index: 11

Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients

Cancers

2024/1/5

Theodoros P Vassilakopoulos
Theodoros P Vassilakopoulos

H-Index: 23

Maria Dimou
Maria Dimou

H-Index: 13

Kostas Konstantopoulos
Kostas Konstantopoulos

H-Index: 14

A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity

2023/12/22

Theodoros P Vassilakopoulos
Theodoros P Vassilakopoulos

H-Index: 23

S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL ANALYSIS OF THE INTERNATIONAL MULTICENTER STUDY CONDUCTED BY ERIC, IN HARMONY.

HemaSphere

2023/8

Georgios Karakatsoulis
Georgios Karakatsoulis

H-Index: 1

Maria Dimou
Maria Dimou

H-Index: 13

Alessandro Gozzetti
Alessandro Gozzetti

H-Index: 22

Ritu Gupta
Ritu Gupta

H-Index: 17

Eleftheria Hatzimichael
Eleftheria Hatzimichael

H-Index: 25

Ivana Milosevic
Ivana Milosevic

H-Index: 9

Mohamed Yassin
Mohamed Yassin

H-Index: 1

Maria Angelopoulou
Maria Angelopoulou

H-Index: 22

Luca Laurenti
Luca Laurenti

H-Index: 12

Panagiotis Panagiotidis
Panagiotis Panagiotidis

H-Index: 5

Paolo Sportoletti
Paolo Sportoletti

H-Index: 24

Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version

Annals of Hematology

2023/8

Penelope Korkolopoulou
Penelope Korkolopoulou

H-Index: 28

Theodoros P Vassilakopoulos
Theodoros P Vassilakopoulos

H-Index: 23

Easix Indices Predict CRS and Overall Survival in Adult CAR-T Cell Recipients

Blood

2023/12/1

Maria Angelopoulou
Maria Angelopoulou

H-Index: 22

EVALUATION OF GONADAL FUNCTION IN YOUNG MEN AND WOMEN DIAGNOSED WITH HODGKIN LYMPHOMA

Hematological Oncology

2023/6

EVALUATION OF FERTILITY IN WOMEN TREATED WITH THE R‐DA‐EPOCH REGIMEN FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA (PMBCL)

Hematological Oncology

2023/6

REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐da‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A MULTINATIONAL ANALYSIS OF 274 PATIENTS

Hematological Oncology

2023/6

TREATMENT STRATEGIES AND PROGNOSTIC FACTORS FOR THE OUTCOME OF PATIENTS WITH HODGKIN LYMPHOMA EXPERIENCING VERY LATE RELAPSES AFTER CHEMOTHERAPY±RADIOTHERAPY

Hematological Oncology

2023/6

Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study

Frontiers in Oncology

2023/3/7

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

EClinicalMedicine

2023/11/1

Georgios Karakatsoulis
Georgios Karakatsoulis

H-Index: 1

Maria Dimou
Maria Dimou

H-Index: 13

Alessandro Gozzetti
Alessandro Gozzetti

H-Index: 22

Ritu Gupta
Ritu Gupta

H-Index: 17

Eleftheria Hatzimichael
Eleftheria Hatzimichael

H-Index: 25

Ivana Milosevic
Ivana Milosevic

H-Index: 9

Mohamed Yassin
Mohamed Yassin

H-Index: 1

Maria Angelopoulou
Maria Angelopoulou

H-Index: 22

Luca Laurenti
Luca Laurenti

H-Index: 12

Panagiotis Panagiotidis
Panagiotis Panagiotidis

H-Index: 5

Paolo Sportoletti
Paolo Sportoletti

H-Index: 24

Effects of chemotherapy on aortic 18-Fluorodeoxyglucose uptake in patients with Hodgkin and non-Hodgkin lymphoma

JACC: Advances

2023/3/1

Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era

Hematological Oncology

2023/2

Theodoros P Vassilakopoulos
Theodoros P Vassilakopoulos

H-Index: 23

Eleftheria Hatzimichael
Eleftheria Hatzimichael

H-Index: 25

Maria Dimou
Maria Dimou

H-Index: 13

PET for Response Assessment to R‐da‐EPOCH in Primary Mediastinal Large B‐cell lymphoma: Who Is Worthy to be Irradiated?

HemaSphere

2023/11

Theodoros P Vassilakopoulos
Theodoros P Vassilakopoulos

H-Index: 23

Eleftheria Hatzimichael
Eleftheria Hatzimichael

H-Index: 25

Evangelos Terpos
Evangelos Terpos

H-Index: 61

Helen Papadaki
Helen Papadaki

H-Index: 18

Argiris Symeonidis
Argiris Symeonidis

H-Index: 28

Incorporating monoclonal antibodies into the first-line treatment of classical Hodgkin lymphoma

2023/8/24

Theodoros P Vassilakopoulos
Theodoros P Vassilakopoulos

H-Index: 23

Prolonged 3-year spontaneous remission of diffuse large B-cell lymphoma upon withdrawal of infliximab and late relapse in a patient with psoriasis: a case report and review of …

2023/8/24

Penelope Korkolopoulou
Penelope Korkolopoulou

H-Index: 28

Theodoros P Vassilakopoulos
Theodoros P Vassilakopoulos

H-Index: 23

P1121: POSITRON EMISSION TOMOGRAPHY FOR FINAL RESPONSE ASSESSMENT TO RITUXIMAB-DOSE ADJUSTED EPOCH IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: WHO IS WORTHY TO BE IRRADIATED?

HemaSphere

2023/8/1

Marina Siakantaris
Marina Siakantaris

H-Index: 16

Eleftheria Hatzimichael
Eleftheria Hatzimichael

H-Index: 25

Evangelos Terpos
Evangelos Terpos

H-Index: 61

Helen Papadaki
Helen Papadaki

H-Index: 18

Maria Angelopoulou
Maria Angelopoulou

H-Index: 22

P051: Serum procalcitonin levels in newly diagnosed classical Hodgkin Lymphoma (cHL): Correlation with other inflammatory biomarkers

HemaSphere

2022/10/1

Theodoros P Vassilakopoulos
Theodoros P Vassilakopoulos

H-Index: 23

Maria Dimou
Maria Dimou

H-Index: 13

Effect of 1st line treatment on aortic inflammation as assessed by 18 FDG PET/CT in patients with Hodgkin and non-Hodgkin lymphoma

European Heart Journal

2022/10/1

See List of Professors in MARIA ANGELOPOULOU University(National and Kapodistrian University of Athens)